Navigation Links
NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
Date:4/4/2013

AMES, Iowa, April 4, 2013 /PRNewswire/ -- NewLink Genetics Corporation (NASDAQ: NLNK) is a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics. The company today announced that preclinical data on one of its IDO pathway inhibitors, NLG919, will be presented at the 2013 Annual Meeting of the American Association for Cancer Research (AACR) to be held April 6-10 in Washington, DC. The poster presentation will describe the benefits of targeting the IDO pathway with small molecule immunomodulatory drugs for the treatment of cancer. NLG919 is in development as a potent IDO pathway inhibitor with desirable pharmacological properties.

Poster presentation:

  • (Poster #491): Sunday, April 7, 2013, 1:00 -5:00 PM, "NLG919, a novel indoleamine-2,3-dioxygenase (IDO)-pathway inhibitor drug candidate for cancer therapy," M. Mautino, Immunology 2: Vaccines, Immune Modulatory Agents, and Environment, Hall A-C, Poster Section 22, in The Washington Convention Center.

About inhibition of the IDO pathway

IDO pathway inhibitors are another class of immune check point inhibitors akin to the recently developed antibodies targeting CTLA-4 and PD-1 which represent a potential breakthrough approach to cancer therapy.  The IDO pathway regulates immune response by suppressing T-cell function and enabling local tumor immune escape. Recent studies have demonstrated that the IDO pathway is active in many cancers, both within tumor cells as a direct defense against T-cell attack, and also within antigen presenting cells in tumor draining lymph nodes whereby this pathway promotes peripheral tolerance to tumor associated antigens (TAAs).  When hijacked by developing cancers in this
'/>"/>

SOURCE NewLink Genetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NewLink Genetics Announces Timing of Fourth Quarter and Year-End 2012 Financial Results Conference Call
2. NewLink Genetics Corporation Announces Exercise of Underwriters Option and Closing of Public Offering of Common Stock
3. NewLink Genetics Corporation Announces Pricing of Public Offering of Common Stock
4. NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
5. Clinical Data from NewLink Genetics HyperAcute Prostate Cancer Immunotherapy Published in Journal of Immunotherapy
6. Lota S. Zoth joins NewLinks Board of Directors; heads Audit Committee
7. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
8. Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics
9. Submit Questions to Nobel Laureates and Other Experts about Genetics and Society
10. The International Serious Adverse Event Consortium and UC San Diego To Collaborate On Research Into The Genetics Of Drug Induced Renal Injury
11. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very pleased ... as its new Chief Executive Officer.  Mark was promoted ... he has overseen the company,s four facilities in ... Rica.  Mr. King joined Tegra Medical in 2012 with 20+ ...
(Date:1/15/2014)... Ill. , Jan. 15, 2014 The Cadence ... Medical Fitness Center by the Medical Fitness Association, a ... to achieve their full potential. The Cadence Fitness & ... the western suburbs and second in the Chicagoland area. ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... ATLANTA, Nov. 28, 2011   CardioMEMS, Inc ., an ... commercializing a proprietary wireless sensing and communication technology for ... CEO, Jay Yadav, M.D. , has been recognized ... Endeavor Awards in the Technology Entrepreneur category. The awards ...
... (NYSE Amex: PIP ), a biodefense company ... today that Eric I. Richman, President and Chief Executive ... Healthcare Conference being held November 29-30, 2011.  ... in one-on-one meetings at the conference.Event : , ...
Cached Medicine Technology:TechAmerica and the Technology Association of Georgia Name Dr. Jay Yadav, CardioMEMS Founder & CEO as a Spirit of Endeavor Award Finalist 2TechAmerica and the Technology Association of Georgia Name Dr. Jay Yadav, CardioMEMS Founder & CEO as a Spirit of Endeavor Award Finalist 3PharmAthene to Present at the Piper Jaffray 23rd Annual Healthcare Conference on November 30, 2011 2
(Date:4/15/2014)... mystery and in the process have found a potentially less ... million people a year. The researchers say they now understand the ... in use for more than 50 years even though it ... the microbes it attacks. , A report of the ...
(Date:4/14/2014)... children orphaned by HIV/AIDS in South Africa may provide insight ... issues in other areas of the world, which may have ... to successful interventions. , A report on the global ... to the HIV/AIDS pandemic, which has left 12 million children ...
(Date:4/14/2014)... shows that moderate to severe obstructive sleep apnea is independently associated ... of the 20-year follow-up study show that people with moderate to ... (hazard ratio = 4.2), nearly four times more likely to have ... from cancer (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... youth offenders, the answer to one open-ended question predicted the ... do you think you,ll live?", According to the study, having ... Dr. Alex Piquero said the study found those who don,t ... very high rates and commit more serious offenses, while those ...
(Date:4/14/2014)... fathers hard -- with symptoms increasing dramatically during some of ... Northwestern Medicine study has found. , Depressive symptoms increased on ... fatherhood for these young men, who were around 25 years ... same home as their children. The results of the study ...
Breaking Medicine News(10 mins):Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2
... Jan. 11 (HealthDay News) -- There is little evidence ... relieve the symptoms of osteoarthritis, according to a review ... that involves damage to cartilage and other structures in ... hips. It differs from rheumatoid arthritis, which is an ...
... of researchers at the California Institute of Technology (Caltech) ... The reaction they have come up with should enable ... of organic compounds called nitrogen-containing heterocycles, thus opening up ... natural products ranging from chemotherapeutic compounds to bioactive plant ...
... Denise Mann HealthDay Reporter , WEDNESDAY, Jan. ... their heart race when they are having an irregular ... double their risk of stroke, a new study finds. ... not have a history of atrial fibrillation, more than ...
... During 2010-2011, University of Louisville Health Sciences Center faculty ... $5.7 million in the four regions of Kentucky served ... faculty from UofL provided donated services valued at $5,606,599 ... living and travel expenses in the four regions. These ...
... -- A genetic mutation that causes a rare immune ... been identified by scientists. Symptoms of the disorder ... (cold urticaria), according to the report published online in ... Journal of Medicine . The U.S. National Institutes ...
... HealthDay Reporter , WEDNESDAY, Jan. 11 (HealthDay News) -- ... type 1 diabetes appears to help re-educate rogue immune system ... insulin again. The treatment, which combines a patient,s ... blood, even worked in people with long-standing diabetes who were ...
Cached Medicine News:Health News:Herbal Medicines for Arthritis Not Backed by Evidence 2Health News:Herbal Medicines for Arthritis Not Backed by Evidence 3Health News:Caltech chemists devise chemical reaction that holds promise for new drug development 2Health News:Caltech chemists devise chemical reaction that holds promise for new drug development 3Health News:Even When Silent, Irregular Heartbeat Linked to Stroke Risk 2Health News:UofL centers have economic impact in excess of $5.7 million 2Health News:UofL centers have economic impact in excess of $5.7 million 3Health News:Gene Research Sheds Light on Rare Immune Disease 2Health News:Novel Stem Cell Treatment May Hold Promise for Type 1 Diabetes 2Health News:Novel Stem Cell Treatment May Hold Promise for Type 1 Diabetes 3
Inquire...
Sterilization: sterilized Yes...
Transparent film for easy visual monitoring of samples...
Microporous tape sheets for covering 96-well plates, square-well or flat-bottom blocks.;...
Medicine Products: